DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Urea/carbamates FAAH MAGL or dual FAAH/MAGL inhibitors and uses thereof

Abstract

Disclosed are compounds that may be used to inhibit the action of fatty acid amide hydrolase (FAAH), monoacylglycerol lipase (MAGL) or dual FAAH/MAGL. More particularly, compounds of formula II ##STR00001## have utility in a variety of therapeutic uses such as treatment of pain, inflammation, neuropathy, or appetite disorder.

Inventors:
; ;
Issue Date:
Research Org.:
Northeastern Univ., Boston, MA (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1632602
Patent Number(s):
10570146
Application Number:
15/328,428
Assignee:
Northeastern University (Boston, MA)
Patent Classifications (CPCs):
C - CHEMISTRY C07 - ORGANIC CHEMISTRY C07D - HETEROCYCLIC COMPOUNDS
DOE Contract Number:  
FG02-00ER45852
Resource Type:
Patent
Resource Relation:
Patent File Date: 07/24/2015
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES; 37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CHEMISTRY

Citation Formats

Makriyannis, Alexandros, Shukla, Vidyanand G., and Alapafuja, Shakiru O. Urea/carbamates FAAH MAGL or dual FAAH/MAGL inhibitors and uses thereof. United States: N. p., 2020. Web.
Makriyannis, Alexandros, Shukla, Vidyanand G., & Alapafuja, Shakiru O. Urea/carbamates FAAH MAGL or dual FAAH/MAGL inhibitors and uses thereof. United States.
Makriyannis, Alexandros, Shukla, Vidyanand G., and Alapafuja, Shakiru O. Tue . "Urea/carbamates FAAH MAGL or dual FAAH/MAGL inhibitors and uses thereof". United States. https://www.osti.gov/servlets/purl/1632602.
@article{osti_1632602,
title = {Urea/carbamates FAAH MAGL or dual FAAH/MAGL inhibitors and uses thereof},
author = {Makriyannis, Alexandros and Shukla, Vidyanand G. and Alapafuja, Shakiru O.},
abstractNote = {Disclosed are compounds that may be used to inhibit the action of fatty acid amide hydrolase (FAAH), monoacylglycerol lipase (MAGL) or dual FAAH/MAGL. More particularly, compounds of formula II ##STR00001## have utility in a variety of therapeutic uses such as treatment of pain, inflammation, neuropathy, or appetite disorder.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2020},
month = {2}
}

Patent:

Works referenced in this record:

Azetidine Ring Compounds and Drugs Comprising the Same
patent-application, June 2007


Heteroaryl-Substituted Urea Modulators of Fatty Acid Amide Hydrolase
patent-application, March 2009


Use of FAAH Inhibitors for Treating Parkinson's Disease and Restless Legs Syndrome
patent-application, June 2013


Fatty Acid Amide Hydrolase Inhibitors from Virtual Screening of the Endocannabinoid System
journal, June 2006


Azetidine derivatives as FAAH inhibitors
patent, May 2013


Methods, Compositions, and Compounds for Modulation of Monoacylglycerol Lipase, Pain and Stress-Related Disorders
patent-application, March 2009


Substituted triazole derivatives as oxytocin antagonists
patent, July 2009


Heteroaryl Substituted Urea Modulators of Fatty Acid Amide Hydrolase
patent-application, March 2014


Monoacylglcerol Lipase Inhibitors for Modulation of Cannabinoid Activity
patent-application, February 2011